Signafuse is indicated for the posterolateral spine, extremities and pelvis as well as a bone graft extender in the posterolateral spine. It is comprised of a biphasic mineral and bioactive glass suspended in a resorbable polymer carrier.
BioStructures is a privately held orthobiologics company.
More Articles on Devices:
Medtronic 3Q Spine Revenues Up, BMP Continues Slump
OrthAlign Signs Exclusive Distribution Agreement With Biomet Japan for KneeAlign
Is Biomet Next to Form IPO?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.